Phenylalanine and tyrosine kinetics in critically Ill children with sepsis

Leticia Castillo, Y. Ming Yu, J. Sergio Marchini, Thomas E. Chapman, Melchor Sanchez, Vernon R. Young, John F. Burke

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

To better understand the impact of severe illness on the amino acid economy and nutritional needs of pediatric patients, we studied plasma phenylalanine and tyrosine kinetics in eleven critically ill patients (six full-term newborns and five young infants). Within 48 h of the diagnosis of sepsis they were given primed constant i.v. infusions of L-[l-13C]phenylalanine and L.-[3,3,2H2]tyrosine for 4 h. Routine nutritional support continued during this period by parenteral administration of dextrose, lipid emulsion, and an amino acid mixture low in tyrosine. Phenylalanine and tyrosine fluxes and rate of phenylalanine hy-droxylation did not differ significantly between the two age groups, and so the data were combined for evaluation. For the entire group, values (μ mol · kg-1 · h-1; mean ± SD) for phenylalanine and tyrosine fluxes and rate of phenylalanine hydroxylation were 132 ± 24, 66 ± 16, and 29 + 12, respectively. Plasma phenylalanine to tyrosine concentration ratio was 1.67 ± 0.6. From a comparison of the rate of phenylalanine hydroxylation with measured phenylalanine intakes, it was concluded that their routine, clinical nutritional support was inadequate to achieve body phenylalanine balance. In comparison with published data, the relative rate of phenylalanine hydroxylation appears to be high. We speculate that tyrosine is a conditionally indispensable amino acid under these conditions; it would be desirable to establish the intake levels and ratio of phenylalanine to tyrosine that effectively support aromatic amino acid balance in these critically ill patients.

Original languageEnglish (US)
Pages (from-to)580-588
Number of pages9
JournalPediatric Research
Volume35
Issue number5
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Phenylalanine
Critical Illness
Tyrosine
Sepsis
Hydroxylation
Nutritional Support
Amino Acids
Aromatic Amino Acids
Emulsions
Age Groups
Newborn Infant
Pediatrics
Lipids
Glucose

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Castillo, L., Yu, Y. M., Marchini, J. S., Chapman, T. E., Sanchez, M., Young, V. R., & Burke, J. F. (1994). Phenylalanine and tyrosine kinetics in critically Ill children with sepsis. Pediatric Research, 35(5), 580-588. https://doi.org/10.1203/00006450-199405000-00009

Phenylalanine and tyrosine kinetics in critically Ill children with sepsis. / Castillo, Leticia; Yu, Y. Ming; Marchini, J. Sergio; Chapman, Thomas E.; Sanchez, Melchor; Young, Vernon R.; Burke, John F.

In: Pediatric Research, Vol. 35, No. 5, 01.01.1994, p. 580-588.

Research output: Contribution to journalArticle

Castillo, L, Yu, YM, Marchini, JS, Chapman, TE, Sanchez, M, Young, VR & Burke, JF 1994, 'Phenylalanine and tyrosine kinetics in critically Ill children with sepsis', Pediatric Research, vol. 35, no. 5, pp. 580-588. https://doi.org/10.1203/00006450-199405000-00009
Castillo, Leticia ; Yu, Y. Ming ; Marchini, J. Sergio ; Chapman, Thomas E. ; Sanchez, Melchor ; Young, Vernon R. ; Burke, John F. / Phenylalanine and tyrosine kinetics in critically Ill children with sepsis. In: Pediatric Research. 1994 ; Vol. 35, No. 5. pp. 580-588.
@article{7b71db5b8063455bb8b5f9794f57e7b6,
title = "Phenylalanine and tyrosine kinetics in critically Ill children with sepsis",
abstract = "To better understand the impact of severe illness on the amino acid economy and nutritional needs of pediatric patients, we studied plasma phenylalanine and tyrosine kinetics in eleven critically ill patients (six full-term newborns and five young infants). Within 48 h of the diagnosis of sepsis they were given primed constant i.v. infusions of L-[l-13C]phenylalanine and L.-[3,3,2H2]tyrosine for 4 h. Routine nutritional support continued during this period by parenteral administration of dextrose, lipid emulsion, and an amino acid mixture low in tyrosine. Phenylalanine and tyrosine fluxes and rate of phenylalanine hy-droxylation did not differ significantly between the two age groups, and so the data were combined for evaluation. For the entire group, values (μ mol · kg-1 · h-1; mean ± SD) for phenylalanine and tyrosine fluxes and rate of phenylalanine hydroxylation were 132 ± 24, 66 ± 16, and 29 + 12, respectively. Plasma phenylalanine to tyrosine concentration ratio was 1.67 ± 0.6. From a comparison of the rate of phenylalanine hydroxylation with measured phenylalanine intakes, it was concluded that their routine, clinical nutritional support was inadequate to achieve body phenylalanine balance. In comparison with published data, the relative rate of phenylalanine hydroxylation appears to be high. We speculate that tyrosine is a conditionally indispensable amino acid under these conditions; it would be desirable to establish the intake levels and ratio of phenylalanine to tyrosine that effectively support aromatic amino acid balance in these critically ill patients.",
author = "Leticia Castillo and Yu, {Y. Ming} and Marchini, {J. Sergio} and Chapman, {Thomas E.} and Melchor Sanchez and Young, {Vernon R.} and Burke, {John F.}",
year = "1994",
month = "1",
day = "1",
doi = "10.1203/00006450-199405000-00009",
language = "English (US)",
volume = "35",
pages = "580--588",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Phenylalanine and tyrosine kinetics in critically Ill children with sepsis

AU - Castillo, Leticia

AU - Yu, Y. Ming

AU - Marchini, J. Sergio

AU - Chapman, Thomas E.

AU - Sanchez, Melchor

AU - Young, Vernon R.

AU - Burke, John F.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - To better understand the impact of severe illness on the amino acid economy and nutritional needs of pediatric patients, we studied plasma phenylalanine and tyrosine kinetics in eleven critically ill patients (six full-term newborns and five young infants). Within 48 h of the diagnosis of sepsis they were given primed constant i.v. infusions of L-[l-13C]phenylalanine and L.-[3,3,2H2]tyrosine for 4 h. Routine nutritional support continued during this period by parenteral administration of dextrose, lipid emulsion, and an amino acid mixture low in tyrosine. Phenylalanine and tyrosine fluxes and rate of phenylalanine hy-droxylation did not differ significantly between the two age groups, and so the data were combined for evaluation. For the entire group, values (μ mol · kg-1 · h-1; mean ± SD) for phenylalanine and tyrosine fluxes and rate of phenylalanine hydroxylation were 132 ± 24, 66 ± 16, and 29 + 12, respectively. Plasma phenylalanine to tyrosine concentration ratio was 1.67 ± 0.6. From a comparison of the rate of phenylalanine hydroxylation with measured phenylalanine intakes, it was concluded that their routine, clinical nutritional support was inadequate to achieve body phenylalanine balance. In comparison with published data, the relative rate of phenylalanine hydroxylation appears to be high. We speculate that tyrosine is a conditionally indispensable amino acid under these conditions; it would be desirable to establish the intake levels and ratio of phenylalanine to tyrosine that effectively support aromatic amino acid balance in these critically ill patients.

AB - To better understand the impact of severe illness on the amino acid economy and nutritional needs of pediatric patients, we studied plasma phenylalanine and tyrosine kinetics in eleven critically ill patients (six full-term newborns and five young infants). Within 48 h of the diagnosis of sepsis they were given primed constant i.v. infusions of L-[l-13C]phenylalanine and L.-[3,3,2H2]tyrosine for 4 h. Routine nutritional support continued during this period by parenteral administration of dextrose, lipid emulsion, and an amino acid mixture low in tyrosine. Phenylalanine and tyrosine fluxes and rate of phenylalanine hy-droxylation did not differ significantly between the two age groups, and so the data were combined for evaluation. For the entire group, values (μ mol · kg-1 · h-1; mean ± SD) for phenylalanine and tyrosine fluxes and rate of phenylalanine hydroxylation were 132 ± 24, 66 ± 16, and 29 + 12, respectively. Plasma phenylalanine to tyrosine concentration ratio was 1.67 ± 0.6. From a comparison of the rate of phenylalanine hydroxylation with measured phenylalanine intakes, it was concluded that their routine, clinical nutritional support was inadequate to achieve body phenylalanine balance. In comparison with published data, the relative rate of phenylalanine hydroxylation appears to be high. We speculate that tyrosine is a conditionally indispensable amino acid under these conditions; it would be desirable to establish the intake levels and ratio of phenylalanine to tyrosine that effectively support aromatic amino acid balance in these critically ill patients.

UR - http://www.scopus.com/inward/record.url?scp=0028262109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028262109&partnerID=8YFLogxK

U2 - 10.1203/00006450-199405000-00009

DO - 10.1203/00006450-199405000-00009

M3 - Article

VL - 35

SP - 580

EP - 588

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -